newsfilter
← Latest News
GlobeNewswire·

Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding

Plus Therapeutics to become Cerenome, to trade under new Nasdaq ticker CNSY on August 3, 2026 Affirms 2026 guidance on key milestones Reports positive CNSide® commercial progress HOUSTON, June 30, 2026 (GLOBE